Data Foundry

Drug recalls 2023

fentaNYL in 0 — Class II drug recall D-0012-2024

Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-10-11, distributed nationwide. Lack of assurance of sterility:

Recall numberD-0012-2024
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCentral Admixture Pharmacy Services Inc, San Diego, CA, United States
Recall initiated2023-09-21
Classified2023-10-04
Reported by FDA2023-10-11
Terminated2025-03-19
DistributedNationwide (US)
Quantity5,378
Reason classessterility
NDC71286-2071-04
Lot numbers17-275314, 17-275319, 17-275320, 17-275324, 17-275327, 17-275328, 17-275349, 17-275510, 17-275531, 17-275536, 17-275541, 17-275548, 17-275656, 17-275714, 17-275766, 17-275786, 17-275787, 17-275802, 17-275918, 17-275926, 17-275951, 17-275966, 17-275975, 17-275977, 17-276103
Expiration dates2023-10-03, 2023-10-05, 2023-10-08, 2023-10-09, 2023-10-10, 2023-10-12, 2023-10-13, 2023-10-15, 2023-10-17

Product

fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4

Reason for recall

Lack of assurance of sterility:

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0012-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.